Cure The Summer Doldrums With Leveraged Biotech ETFs By: Benzinga via Benzinga June 30, 2017 at 14:40 PM EDT The summer months can be a lethargic period for equities. While that scenario can lead some investors to flock to defensive sectors, ... Read More >> Related Stocks: S&P Biotech Bull 3X Direxion